The Tour of California will continue under the banner of pharmaceutical giant Amgen for the seventh consecutive year. AEG vice president Kristin Bachochin confirmed the news to Cyclingnews today.
"We are happy and pleased to confirm that Amgen will remain as the title sponsor of the 2012 race," Bachochin said.
Amgen has partnered with the race since its inception, using the race to promote its cancer advocacy initiatives. In conjunction with the race and non-profit partners, Amgen launched the Breakaway from Cancer to promote awareness of resources for cancer patients.
The Amgen Tour of California will begin in Santa Rosa in 2012.
Enjoy your first month for just £1 / $1 / €1
*Read 5 free articles per month without a subscription
Try your first month for just £1 / $1 / €1
Laura Weislo has been with Cyclingnews since 2006 after making a switch from a career in science. As Deputy Editor, she coordinates coverage for North American events and global news. As former elite-level road racer who dabbled in cyclo-cross and track, Laura has a passion for all three disciplines. When not working she likes to go camping and explore lesser traveled roads, paths and gravel tracks.
Thank you for signing up to Cycling News. You will receive a verification email shortly.
There was a problem. Please refresh the page and try again.